Revolution Medicines Inc
(RVMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 50,041 | 20,165 | 0 | 0 | 0 |
| Gross Profit | 50,041 | 20,165 | N/A | N/A | N/A |
| Operating Expenses | 104,161 | 60,494 | 31,129 | 0 | 0 |
| Operating Income | -54,120 | -40,329 | -31,129 | N/A | N/A |
| Interest Expense | 106 | 116 | 103 | 0 | 0 |
| Other Income | 2,189 | -1,344 | 105 | 0 | 0 |
| Pre-tax Income | -52,037 | -41,789 | -31,127 | 0 | 0 |
| Income Tax | -4,373 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -47,664 | -41,789 | -31,127 | N/A | N/A |
| Net Income | $-47,664 | $-41,789 | $-31,127 | $N/A | $N/A |
| EPS Basic Total Ops | -22.33 | -21.24 | -20.25 | N/A | N/A |
| EPS Basic Continuous Ops | -17.19 | -18.18 | -18.07 | N/A | N/A |
| EPS Diluted Total Ops | -22.33 | -21.24 | -20.25 | N/A | N/A |
| EPS Diluted Continuous Ops | -17.19 | -18.18 | -18.07 | N/A | N/A |
| EBITDA(a) | $-51,228 | $-38,565 | $-29,941 | $N/A | $N/A |